Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Peifer

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 4, 2019
K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic PathwaysMatthias Scheffler, Michaela A Ihle, Rebecca Hein, et al.
Genome Biology|February 5, 2015
Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing dataLynnette Fernandez-Cuesta, Ruping Sun, Roopika Menon, et al.
Nature|February 7, 2020
The evolutionary history of 2,658 cancersMoritz Gerstung, Clemency Jolly, Ignaty Leshchiner, et al.
Nature|January 25, 2023
Author Correction: The evolutionary history of 2,658 cancersMoritz Gerstung, Clemency Jolly, Ignaty Leshchiner, et al.
Nature Communications|March 28, 2014
Frequent mutations in chromatin-remodelling genes in pulmonary carcinoidsLynnette Fernandez-Cuesta, Martin Peifer, Xin Lu, et al.
The Journal of Clinical Investigation|May 20, 2009
Predicting drug susceptibility of non-small cell lung cancers based on genetic lesionsMartin L Sos, Kathrin Michel, Thomas Zander, et al.
Science (New York, N.Y.)|December 8, 2018
A mechanistic classification of clinical phenotypes in neuroblastomaSandra Ackermann, Maria Cartolano, Barbara Hero, et al.
The Journal of Clinical Investigation|February 12, 2026
Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastomaLisa Werr, Jana Boland, Josephine Petersen, et al.
Cell|April 8, 2021
Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomesStefan C Dentro, Ignaty Leshchiner, Kerstin Haase, et al.
Cancer Discovery|January 29, 2014
CD74-NRG1 fusions in lung adenocarcinomaLynnette Fernandez-Cuesta, Dennis Plenker, Hirotaka Osada, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 4, 2019
K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic PathwaysMatthias Scheffler, Michaela A Ihle, Rebecca Hein, et al.
Genome Biology|February 5, 2015
Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing dataLynnette Fernandez-Cuesta, Ruping Sun, Roopika Menon, et al.
Nature|February 7, 2020
The evolutionary history of 2,658 cancersMoritz Gerstung, Clemency Jolly, Ignaty Leshchiner, et al.
Nature|January 25, 2023
Author Correction: The evolutionary history of 2,658 cancersMoritz Gerstung, Clemency Jolly, Ignaty Leshchiner, et al.
Nature Communications|March 28, 2014
Frequent mutations in chromatin-remodelling genes in pulmonary carcinoidsLynnette Fernandez-Cuesta, Martin Peifer, Xin Lu, et al.
The Journal of Clinical Investigation|May 20, 2009
Predicting drug susceptibility of non-small cell lung cancers based on genetic lesionsMartin L Sos, Kathrin Michel, Thomas Zander, et al.
Science (New York, N.Y.)|December 8, 2018
A mechanistic classification of clinical phenotypes in neuroblastomaSandra Ackermann, Maria Cartolano, Barbara Hero, et al.
The Journal of Clinical Investigation|February 12, 2026
Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastomaLisa Werr, Jana Boland, Josephine Petersen, et al.
Cell|April 8, 2021
Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomesStefan C Dentro, Ignaty Leshchiner, Kerstin Haase, et al.
Cancer Discovery|January 29, 2014
CD74-NRG1 fusions in lung adenocarcinomaLynnette Fernandez-Cuesta, Dennis Plenker, Hirotaka Osada, et al.
Pageof 11